Cigarette use and cardiovascular risk in chronic kidney disease: an unappreciated modifiable lifestyle risk factor.

Hdl Handle:
http://hdl.handle.net/10147/205736
Title:
Cigarette use and cardiovascular risk in chronic kidney disease: an unappreciated modifiable lifestyle risk factor.
Authors:
Stack, Austin G; Murthy, Bhamidipati V R
Affiliation:
Regional Kidney Centre, Department of Medicine, Letterkenny General Hospital,, Health Services Executive, County Donegal, Ireland. austin.stack@hse.ie
Citation:
Semin Dial. 2010 May-Jun;23(3):298-305.
Journal:
Seminars in dialysis
Issue Date:
31-Jan-2012
URI:
http://hdl.handle.net/10147/205736
DOI:
10.1111/j.1525-139X.2010.00728.x
PubMed ID:
20636923
Abstract:
Tobacco use is a major modifiable cardiovascular risk factor in the general population and contributes to excess cardiovascular risk. Emerging evidence from large-scale observational studies suggests that continued tobacco use is also an independent cardiovascular risk factor among patients with chronic kidney disease (CKD). The benefits of smoking cessation programs on improving the heath status of patients and reducing mortality are unequivocal in the general population. Despite this, there has been little effort in pursuing tobacco cessation programs in dialysis cohorts or those with lesser degrees of kidney impairment. Most of our attention to date has focused on the development of "kidney-specific" interventions that reduce rates of renal disease progression and improve dialysis outcomes. The purpose of this current review is to describe the epidemiology of tobacco use among patients with CKD, draw attention to its negative impact on cardiovascular morbidity and mortality, and finally highlight potential strategies for successful intervention. We hope that this study heightens the importance of tobacco use in CKD, stimulates renewed interest in the barriers and challenges that exist in achieving smoking cessation, and endorses the efficacy of intervention strategies and the immeasurable benefits of quitting on cardiovascular and noncardiovascular outcomes.
Language:
eng
MeSH:
*Cardiovascular Diseases/epidemiology/etiology/prevention & control; Humans; Incidence; Kidney Failure, Chronic/*complications; *Life Style; Prognosis; Risk Factors; Smoking/*adverse effects/epidemiology; Smoking Cessation/methods; Survival Rate/trends
ISSN:
1525-139X (Electronic); 0894-0959 (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorStack, Austin Gen_GB
dc.contributor.authorMurthy, Bhamidipati V Ren_GB
dc.date.accessioned2012-01-31T16:31:18Z-
dc.date.available2012-01-31T16:31:18Z-
dc.date.issued2012-01-31T16:31:18Z-
dc.identifier.citationSemin Dial. 2010 May-Jun;23(3):298-305.en_GB
dc.identifier.issn1525-139X (Electronic)en_GB
dc.identifier.issn0894-0959 (Linking)en_GB
dc.identifier.pmid20636923en_GB
dc.identifier.doi10.1111/j.1525-139X.2010.00728.xen_GB
dc.identifier.urihttp://hdl.handle.net/10147/205736-
dc.description.abstractTobacco use is a major modifiable cardiovascular risk factor in the general population and contributes to excess cardiovascular risk. Emerging evidence from large-scale observational studies suggests that continued tobacco use is also an independent cardiovascular risk factor among patients with chronic kidney disease (CKD). The benefits of smoking cessation programs on improving the heath status of patients and reducing mortality are unequivocal in the general population. Despite this, there has been little effort in pursuing tobacco cessation programs in dialysis cohorts or those with lesser degrees of kidney impairment. Most of our attention to date has focused on the development of "kidney-specific" interventions that reduce rates of renal disease progression and improve dialysis outcomes. The purpose of this current review is to describe the epidemiology of tobacco use among patients with CKD, draw attention to its negative impact on cardiovascular morbidity and mortality, and finally highlight potential strategies for successful intervention. We hope that this study heightens the importance of tobacco use in CKD, stimulates renewed interest in the barriers and challenges that exist in achieving smoking cessation, and endorses the efficacy of intervention strategies and the immeasurable benefits of quitting on cardiovascular and noncardiovascular outcomes.en_GB
dc.language.isoengen_GB
dc.subject.mesh*Cardiovascular Diseases/epidemiology/etiology/prevention & controlen_GB
dc.subject.meshHumansen_GB
dc.subject.meshIncidenceen_GB
dc.subject.meshKidney Failure, Chronic/*complicationsen_GB
dc.subject.mesh*Life Styleen_GB
dc.subject.meshPrognosisen_GB
dc.subject.meshRisk Factorsen_GB
dc.subject.meshSmoking/*adverse effects/epidemiologyen_GB
dc.subject.meshSmoking Cessation/methodsen_GB
dc.subject.meshSurvival Rate/trendsen_GB
dc.titleCigarette use and cardiovascular risk in chronic kidney disease: an unappreciated modifiable lifestyle risk factor.en_GB
dc.contributor.departmentRegional Kidney Centre, Department of Medicine, Letterkenny General Hospital,, Health Services Executive, County Donegal, Ireland. austin.stack@hse.ieen_GB
dc.identifier.journalSeminars in dialysisen_GB
dc.description.provinceUlster-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.